| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
17,070,000 |
| Market
Cap: |
92.01(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.39 - $5.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NeuBase Therapeutics is a pre-clinical-stage biopharmaceutical company. Co. is developing a modular peptide-nucleic acid antisense oligo (PATrOL™) platform to address genetic diseases. Co.'s programs are: NT0100, which is a PATrOL™-enabled therapeutic program being developed to target the mutant expansion in the Huntington's disease messenger ribonucleic acid; NT0200, which is a PATrOL™-enabled therapeutic program being developed to target the mutant expansion in the myotonic dystrophy type 1 disease messenger ribonucleic acid; and NT-0300, which is a PATrOL-enabled therapeutic program being developed to target the mutated KRAS gene.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
61,076 |
61,076 |
| Total Buy Value |
$0 |
$0 |
$59,732 |
$59,732 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
489,520 |
489,520 |
| Total Sell Value |
$0 |
$0 |
$712,352 |
$712,352 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
6 |
6 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Symetryx Corp |
10% Owner |
– – • |
2023-09-18 |
4 |
S |
$1.19 |
$59,500 |
D/D |
(50,000) |
0 |
|
- |
|
| Symetryx Corp |
10% Owner |
– – • |
2023-09-15 |
4 |
S |
$1.26 |
$130,205 |
D/D |
(103,337) |
50,000 |
|
- |
|
| Symetryx Corp |
10% Owner |
– – • |
2023-09-14 |
4 |
S |
$1.44 |
$185,916 |
D/D |
(129,108) |
153,337 |
|
- |
|
| Symetryx Corp |
10% Owner |
– – • |
2023-09-11 |
4 |
S |
$1.44 |
$4,861 |
D/D |
(3,376) |
472,926 |
|
- |
|
| Symetryx Corp |
10% Owner |
– – • |
2023-09-08 |
4 |
S |
$1.53 |
$197,136 |
D/D |
(128,847) |
476,302 |
|
- |
|
| Symetryx Corp |
10% Owner |
– – • |
2023-09-07 |
4 |
S |
$1.80 |
$134,734 |
D/D |
(74,852) |
605,149 |
|
- |
|
| Symetryx Corp |
10% Owner |
– – • |
2023-09-01 |
4 |
B |
$0.98 |
$59,732 |
D/D |
61,076 |
680,081 |
2.45 |
- |
|
| Shiff Aleta |
10% Owner |
– – • |
2023-08-23 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
190,481 |
|
- |
|
| Stephan Dietrich A |
Founder and CEO |
• • • |
2023-08-02 |
4 |
OE |
$0.02 |
$2,051 |
D/D |
93,234 |
93,234 |
|
- |
|
| Stephan Dietrich A |
CEO and Director |
• • • |
2023-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
153,000 |
153,000 |
|
- |
|
| Branning Todd P. |
Chief Financial Officer |
• – – |
2023-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,200 |
84,200 |
|
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2023-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
655,000 |
1,471,775 |
|
- |
|
| Stephan Dietrich A |
CEO |
• • • |
2022-09-28 |
4 |
OE |
$0.00 |
$825 |
D/D |
750,000 |
816,775 |
|
- |
|
| Mann William Roland |
Chief Operating Officer |
• – – |
2022-03-30 |
4 |
B |
$1.92 |
$11,904 |
D/D |
6,200 |
11,200 |
2.74 |
- |
|
| Branning Todd P. |
Chief Financial Officer |
• – – |
2022-03-18 |
4 |
B |
$1.81 |
$18,100 |
D/D |
10,000 |
30,000 |
2.74 |
- |
|
| Branning Todd P. |
Chief Financial Officer |
• – – |
2022-03-17 |
4 |
B |
$1.74 |
$17,400 |
D/D |
10,000 |
20,000 |
2.74 |
- |
|
| Branning Todd P. |
Chief Financial Officer |
• – – |
2022-03-16 |
4 |
B |
$1.62 |
$16,200 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Richman Eric I |
Director |
– • – |
2022-03-04 |
4 |
B |
$1.62 |
$1,620 |
D/D |
1,000 |
44,960 |
2.31 |
- |
|
| Richman Eric I |
Director |
– • – |
2022-03-03 |
4 |
B |
$1.72 |
$2,236 |
D/D |
1,300 |
43,960 |
2.31 |
- |
|
| Richman Eric I |
Director |
– • – |
2022-03-01 |
4 |
B |
$1.58 |
$2,496 |
D/D |
1,580 |
42,660 |
2.31 |
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2021-12-31 |
4 |
OE |
$0.00 |
$42 |
D/D |
42,250 |
66,775 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2021-06-18 |
4 |
B |
$4.75 |
$38,000 |
D/D |
8,000 |
30,000 |
2.39 |
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2021-04-26 |
4 |
B |
$5.00 |
$60,000 |
D/D |
12,000 |
22,000 |
2.39 |
- |
|
| Stephan Dietrich A |
President and CEO |
• • • |
2021-04-26 |
4 |
B |
$5.00 |
$60,000 |
D/D |
12,000 |
24,525 |
3.23 |
- |
|
| Richman Eric I |
Director |
– • – |
2021-04-26 |
4 |
B |
$5.00 |
$25,000 |
D/D |
5,000 |
41,080 |
2.39 |
- |
|
84 Records found
|
|
Page 1 of 4 |
|
|
